Skip to main content

Latest collections open to submissions

NEW: Diet and physical activity during and after cancer treatment

Guest Edited by Nicolas H. Hart and Dominic O’Connor

NEW: Immunology and immunotherapy in solid cancers

Guest Edited by Zachary C. Hartman and Daniel Smrz

Editors' Picks

New Content ItemNovel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells

New Content ItemInhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer

New Content ItemA role for SETD2 loss in tumorigenesis through DNA methylation dysregulation

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!


Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions

Aims and Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

Urological Cancers Awareness Month

July - Sarcoma Awareness Month

Urological Cancers Awareness Month runs for the whole of September. We hope you will enjoy reading the following article recently published in BMC Cancer highlighting the importance of biomarkers in for urothelial bladder cancer patient stratification to help avoiding unnecessary interventions whilst indicating aggressive measures when required.

New Content ItemElevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Become an Editorial Board Member

We are recruiting new Editorial Board Members.

Read More

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    11,097 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal